PEG(E)-TC-11

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NamePEG(E)-TC-11
Drug Alias NamePEG(E)-TC11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsCell cycle inhibitorsNucleophosmin inhibitors +[5] 
TargetsNucleophosminTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIdac Theranostics IncKeio UniversitySaitama University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIdac Theranostics IncSaitama UniversityKeio University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A